MedTech Dive January 25, 2024
Nick Paul Taylor

The reorganization establishes new divisions at the Office of Strategic Partnerships and Technology Innovation to account for its growth since 2019.

Dive Brief:

  • The Food and Drug Administration has elevated and expanded an office that handles activities including medical device cybersecurity and digital health.
  • Effective immediately, the Office of Strategic Partnerships and Technology Innovation (OST) has become a “super office.” The reorganization creates new divisions and programs at the OST to account for its growth since 2019 and raise the profile of digital health work.
  • The five offices housed in the OST will lead the FDA’s medical device resilient supply chain and shortages program, drive the development of voluntary consensus standards and work on new approaches to digital health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Cybersecurity, FDA, Govt Agencies, Health IT, Medical Devices, Supply Chain, Technology
Related Articles:
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
11 drugs now in shortage
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
FDA Launches ‘Home as a Health Care Hub’ Initiative With Equity Focus

Share This Article